Product Details
Octreotide for Injectable Suspension
Octreotide10 mg
Powder for Injectable Suspension
Vial + Diluent in Prefilled Syringe Kit
DIN/PIN/NPN
02503751
Manufacturer
Teva Canada Limited
Formulary Listing Date
2021-11-30
Unit Price
990.6975
Amount MOH Pays
990.6975
Coverage Status
General Benefit
ODB Formulary Therapeutic Classification
Therapeutic Note
NO
ATC Code
H01CB02
Interchangeable Products
| DIN/ PIN/ NPN | Brand name | Unit Price | Amount MOH pays |
|---|---|---|---|
| 02239323 | Sandostatin LAR | 1320.9300 | 990.6975 |
| 02503751 | Octreotide for Injectable Suspension | 990.6975 | 990.6975 |